(Q35224956)

7 August 2017

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents (English)

1 reference

7 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

Lynne M Mofenson

6

0 references

Elizabeth Smith

7

object named as

Elizabeth Smith

1 reference

7 August 2017

Jennifer J Kiser

1

1 reference

7 August 2017

Richard M Rutstein

2

1 reference

7 August 2017

Pearl Samson

3

1 reference

7 August 2017

Bobbie Graham

4

1 reference

7 August 2017

Grace Aldrovandi

5

1 reference

7 August 2017

Steven Schnittman

8

1 reference

7 August 2017

Terry Fenton

9

1 reference

7 August 2017

Richard C Brundage

10

1 reference

7 August 2017

Courtney V Fletcher

11

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

7 August 2017

1 reference

7 August 2017

25

1 reference

7 August 2017

12

1 reference

7 August 2017

1489-1496

1 reference

International perspectives, progress, and future challenges of paediatric HIV infection

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE st

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

A comprehensive review of the natural history of Helicobacter pylori infection in children.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177533

10.1097/QAD.0B013E328348FC41

26 September 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference